Seres Therapeutics (MCRB) FCF Margin Growth (1y) (2017 - 2023)
Seres Therapeutics (MCRB) FCF Margin Growth (1y) (2017 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -89.00 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -1,183.00 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 26,102.00 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 869.00 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 769.00 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 4,109.00 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 19,111.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 811.00 |
| 10 | Seres Therapeutics | 43.87 Mn | 43.87 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 581,713.00 |
| Sep 30, 2023 | -1.58 Mn |
| Jun 30, 2023 | 452,141.00 |
| Mar 31, 2023 | -1.04 Mn |
| Dec 31, 2022 | -505,384.00 |
| Sep 30, 2022 | -186,726.00 |
| Jun 30, 2022 | -371,205.00 |
| Mar 31, 2022 | -385,174.00 |
| Dec 31, 2021 | 81,494.00 |
| Sep 30, 2021 | 194,754.00 |
| Jun 30, 2021 | -26,777.00 |
| Mar 31, 2021 | -19,507.00 |
| Dec 31, 2020 | -127,465.00 |
| Sep 30, 2020 | -148,082.00 |
| Jun 30, 2020 | -37,522.00 |
| Mar 31, 2020 | 4,642.00 |
| Dec 31, 2019 | -40,985.00 |
| Sep 30, 2019 | -7,635.00 |
| Jun 30, 2019 | 46,325.00 |
| Mar 31, 2019 | 24,424.00 |